Reports Outline Follicular Lymphoma Study Results from Denise Wolff et al (AMCP Market Insights: Managed care approaches to bispecific antibodies with a focus on follicular lymphoma and diffuse large B-cell lymphoma): Oncology – Follicular Lymphoma
Researchers from University of Utah Report Findings in Managed Care and Specialty Pharmacy (Optimization of Oncology Biomarker Testing In Managed Care: Best Practices and Consensus Recommendations From an Amcp Market Insights Program): Drugs and Therapies – Managed Care and Specialty Pharmacy
Findings from Ryan Haumschild et al Update Understanding of Mucopolysaccharidoses (AMCP Market Insights: The role of managed care in improving patient care in mucopolysaccharidoses): Nutritional and Metabolic Diseases and Conditions – Mucopolysaccharidoses
This infographic roadmap outlines essential points to better retinal disease management and improve treatment for populations of patients with diabetes at high risk for blindness.
This infographic on Bispecific antibodies describes important things about bsAbs for health care organizations to consider, like choosing the right medication for the right patient and making sure they are available to all patients who might need them.
To discuss managed care approaches to bsAbs with a focus on FL and DLBCL, AMCP Market Insights virtually convened an expert panel of managed care stakeholders in April 2025.
To discuss navigating the rapidly changing landscape of ER+/HER2− metastatic breast cancer (mBC), AMCP Market Insights virtually convened an expert panel of managed care stakeholders in February 2025.
In September 2024, AMCP and Impact Education, LLC, held a virtual Market Insights summit with chief medical and pharmacy officers and other senior health care executives to discuss the management of retinal diseases in patients with diabetes.
Idiopathic hypersomnia (IH) is a chronic, neurologic disorder with a primary symptom of excessive daytime sleepiness
Findings published in JMCP for a 3-phase AMCP Market Insights program on Food Allergies that included a national survey of managed care professionals, in-depth interviews with managed care experts, and a moderated virtual roundtable discussion including clinical and managed care experts.
Key insights from the discussion related to supporting patient needs in MS, advancing understanding of MS, emerging treatments in MS, using real-world evidence in MS coverage decision-making, and addressing continued challenges in MS. Suggested payer best practices in MS also emerged from the discussion.
Retinal diseases in patients with diabetes pose signi cant challenges for health care systems. With a high treatment burden and advances in durable therapies, managed care organizations can optimize patient care by addressing coverage barriers that impact timely treatment with anti-VEGF therapies. This roadmap outlines essential points to better retinal disease management and improve treatment for populations of patients with diabetes at high risk for blindness.
